Reversal of chronic ischemic myocardial dysfunction after transluminal coronary angioplasty

Department of Medicine, Mount Sinai School of Medicine, University of New York, New York.

From a cohort of patients referred for elective transluminal coronary angioplasty, a subset of patients was evaluated to determine whether revascularization using coronary angioplasty could salvage chronically ischemic myocardium. Reversible chronic ischemic left ventricular dysfunction was identified by a severe wall motion abnormality at rest and at least one of the following: 1) persistent angina pectoris; 2) postextrasystolic ventricular contraction potentiation of motion in the asynergic zone on baseline ventriculogram; and 3) thallium-201 uptake in the asynergic zone. Twelve patients were identified as having reversible chronic ischemia and underwent coronary angioplasty. Their mean age was 63 +/- 11 years and duration of symptoms 8.3 +/- 9.7 weeks. Immediate pre- and postangioplasty left ventriculograms were obtained. Regional wall motion was analyzed using a radial axis model, and global ejection fraction was calculated. After angioplasty, tension development (heart rate-systolic pressure product) increased in the absence of an increase in left ventricular end-diastolic pressure. Global ejection fraction increased from 46 +/- 20 to 62 +/- 19% (p less than 0.005). The percent of left ventricular diastolic perimeter showing asynergy decreased from 29 +/- 11 to 10 +/- 13% (p less than 0.005). During follow-up ranging from 6 to 51 months, sudden death occurred in one patient who had had no improvement in wall motion after angioplasty, repeat angioplasty was performed in three patients and eight patients remained asymptomatic. Application of easily obtainable clinical data identifies a subset of patients with chronically ischemic myocardium. Coronary angioplasty in such patients is useful in salvaging hibernating myocardium.

This article has been cited by other articles:

				F Alamanni, A Parolari, A Repossini, E Doria, F Bortone, J Campolo, M Pepi, E Sisillo, M Naliato, R Bigi, et al. Coronary blood flow, metabolism, and function in dysfunctional viable myocardium before and early after surgical revascularisation Heart, November 1, 2004; 90(11): 1291 - 1298. [Abstract] [Full Text] [PDF]

				M. Cohen, G. F. Gensini, F. Maritz, E. P. Gurfinkel, K. Huber, A. Timerman, M. Krzeminska-Pakula, J. Santopinto, C. Hecquet, L. Vittori, et al. Prospective Evaluation of Clinical Outcomes After Acute ST-Elevation Myocardial Infarction in Patients Who Are Ineligible for Reperfusion Therapy: Preliminary Results From the TETAMI Registry and Randomized Trial Circulation, October 21, 2003; 108(90161): III-14 - 21. [Abstract] [Full Text] [PDF]

				E. R. Schwarz, T. Reffelmann, F. Schoendube, B. Herrmanns, R. Chakupurakal, H. Doerge, T. Schuetz, M. Foresti, B. J. Messmer, P. W. Radke, et al. Hypoxic Hypoperfusion Fails to Induce Myocardial Hibernation in Anesthetized Swine Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1999; 4(4): 235 - 247. [Abstract] [PDF]

				W. T. Abraham Pharmacologic Management of Chronic Heart Failure: A Review Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 1998; 2(3): 168 - 190. [Abstract] [PDF]

				A. N. Kitsiou, G. Srinivasan, A. A. Quyyumi, R. M. Summers, S. L. Bacharach, and V. Dilsizian Stress-Induced Reversible and Mild-to-Moderate Irreversible Thallium Defects : Are They Equally Accurate for Predicting Recovery of Regional Left Ventricular Function After Revascularization? Circulation, August 11, 1998; 98(6): 501 - 508. [Abstract] [Full Text] [PDF]

				R. A. Kloner, R. Bolli, E. Marban, L. Reinlib, and E. Braunwald Medical and Cellular Implications of Stunning, Hibernation, and Preconditioning : An NHLBI Workshop Circulation, May 19, 1998; 97(18): 1848 - 1867. [Full Text] [PDF]

				P. G. Camici, W. Wijns, M. Borgers, R. De Silva, R. Ferrari, J. Knuuti, A. A. Lammertsma, A. J. Liedtke, G. Paternostro, and S. F. Vatner Pathophysiological Mechanisms of Chronic Reversible Left Ventricular Dysfunction due to Coronary Artery Disease (Hibernating Myocardium) Circulation, November 4, 1997; 96(9): 3205 - 3214. [Full Text]

				L. L. Mickleborough, H. Maruyama, Y. Takagi, S. Mohamed, Z. Sun, and L. Ebisuzaki Results of Revascularization in Patients With Severe Left Ventricular Dysfunction Circulation, November 1, 1995; 92(9): 73 - 79. [Abstract] [Full Text]

				D. W. Baker, R. Jones, J. Hodges, B. M. Massie, M. A. Konstam, and E. A. Rose Management of Heart Failure: III. The Role of Revascularization in the Treatment of Patients With Moderate or Severe Left Ventricular Systolic Dysfunction JAMA, November 16, 1994; 272(19): 1528 - 1534. [Abstract] [PDF]

				S. L. Lansman, M. Cohen, J. D. Galla, J. Machac, C. S. Quintana, M. A. Ergin, and R. B. Griepp Coronary bypass with ejection fraction of 0.20 or less using centigrade cardioplegia: Long-term follow-up Ann. Thorac. Surg., September 1, 1993; 56(3): 480 - 486. [Abstract] [PDF]